Home > Education Hub > Publications

Filtering options

Advanced Analytics

Agreement Studies

Bayesian Design

Biologics

Biometrics

Biostatistics

Biotech

Bordeaux

Business Strategy

CDMO

Clinical

Clinical Operations

Clinical Trial Management

Clinical Trials

CMC

Contract Development and Manufacturing

CRO

Crowdfunding

Data Science

Data Specialist

Decentralized Clinical Trials

Dermatology

Diagnotics

Digital Health

Digital Therapeutics

Digital Transformation

Diversity

DPHARM

Drug Development

DTx

DTx trends

Due Diligence

eCOA

European Medicines Agency

France

Genomic Testing

Healthcare Technology

Hybrid Clinical Trials

In-Vitro Diagnostic Regulation

Inclusion

Investor Relations

IVDR

Life Sciences

M&A

Market Access

Medical Devices

Medical Robotics

MedTech

Mobile Tech

Oncology

Orphan Drug

Outsourcing Clinical Trials

Patient Advocacy

Patient Centric

Patient Centricity

Patient Engagement

Pharma

Product Development

Rare Disease

Rare Disease Trials

Real-World Evidence

Registry-based studies

Regulatory

Research & Development

Research and Development

Robotcs

RWE

Spain

Startups

Therapeutics

Vaccines

All

Publications

Publications October 5, 2022

Relative Weight of the Variables Evaluated Through the Therapeutic Positioning Reports in the Pricing and Reimbursement of Oncological and Oncohematology Medicines in Spain

Discover how companies’ target prices are impacted by the different variables leveraged during the P&R process for oncology and oncohematology’s first indication.

Market Access Oncology Spain

Publications September 16, 2022

Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials

The rise of technology in clinical research allows us to capture meaningful aspects of health in clinical study participants.

Biometrics Clinical eCOA

Publications September 14, 2022

The Promise and Reality of Decentralized and Hybrid Clinical Trials in Europe Today

To understand the challenges related to hybrid and decentralized trials and ways to overcome them, we spoke with Dr. Hervé Solatges, Product Management, Evidence, and Innovation (DCT(...)

Clinical Decentralized Clinical Trials Hybrid Clinical Trials

Publications September 5, 2022

Taking In-Licensed Biologics to Market: Challenges, Complexities, and Ways to Overcome Them

Taking a biologic through drug development to market is highly complex and filled with challenges. To understand these challenges, their implications and how to overcome them, we spoke(...)

Biologics Clinical Drug Development

Publications September 1, 2022

Determine Your Priorities to Finding the Right CDMO

In this article, we will detail the best practices for working with a CDMO to ensure the success of your product development. After having identified the need for engaging a CDMO, the(...)

Biotech CDMO Contract Development and Manufacturing

Publications August 25, 2022

Why—and When—to Use a CDMO

Pharmaceutical development companies of all sizes frequently outsource their Active Pharmaceutical Ingredient (API) manufacturing to CDMOs for various reasons. In this article, we explore(...)

CDMO Pharma Research and Development

Latest from Alira Health

Events October 7, 2022

Debate Sobre los IPT en Oncología

We are pleased to announce our next event, “Debate Sobre los IPT en Oncología,” focusing on price and reimbursement (P&R) of vital oncology and oncohematology therapies.

Market Access Product Development Regulatory

Events October 6, 2022

The MedTech Conference 2022

We are pleased to share that we will be joining the MedTech Conference 2022 as sponsors and speakers! This year’s edition will have more than 100 sessions focusing on today’s hot topics.

M&A MedTech Regulatory

Events October 3, 2022

European Statistical Forum 2022

We are pleased to share that we will be joining the European Statistical Forum this year. This key for statistical experts event will include presentations on such topics as reproducibility,(...)

Biostatistics Data Science

Multimedia September 29, 2022

Regulatory Strategy for Registering Rare Disease Products in the EU

In this webinar we will focus on how to benefit, today and in the future, from the orphan drug program and build a regulatory strategy for successful rare disease product registration(...)

Drug Development Rare Disease Regulatory

Multimedia September 8, 2022

HealthBiz Podcast: Interview with Gabriele Brambilla

Gabriele Brambilla, CEO of Alira Health, has joined the HealthBiz podcast to discuss how Alira Health strives to achieve its mission of humanizing healthcare, the importance of seeing(...)

Life Sciences Patient Centricity Product Development

Multimedia August 30, 2022

Business Strategy and Go-to-Market in Medical Robotics

We are pleased to announce that on September 27 we will co-host an online workshop “Business Strategy and Go-to-Market in Medical Robotics” with The Hamlyn Centre for Robotic Surgery.

Business Strategy Medical Robotics

News October 4, 2022

Alira Health enhances its market access services through a strategic partnership with Centivis

Alira Health, a global healthcare advisory and technology company, announced a strategic partnership with Centivis AG, a boutique market access consulting agency, specializing in digital(...)

Digital Health Market Access MedTech Pharma Regulatory

News September 27, 2022

AseBio and Alira Health Partner to Foster Market Access for Biotech Startups

Alira Health and AseBio, the Spanish Bioindustry Association, are joining forces to support Spanish biotech companies looking to enter new markets.

Biotech Market Access Startups

News September 6, 2022

Alira Health Expands North American Capabilities with the Acquisition of Artisan Healthcare Consulting

The acquisition of Artisan strengthens and extends Alira Health’s Market Access and Management Consulting advisory practices in North America and globally.

Biotech Market Access Pharma Therapeutics

View all Events